Increased fibrinaloid microclot counts in platelet-poor plasma are associated with Long COVID
Dalton, C. F.; de Oliveira, M. I.; Stafford, P.; Peake, N.; Kane, B.; Higham, A.; Singh, D.; Jackson, N.; Davies, H.; Price, D.; Duncan, R.; Tattersall, N.; Barnes, A.; Smith, D. P.
Show abstract
Outcomes following SARS-CoV-2 infection are variable; whilst the majority of patients recover without serious complications, a subset of patients develop prolonged illness termed Long COVID or post-acute sequelae of SARS-CoV-2 infection (PASC). The pathophysiology underlying Long COVID remains unclear but appears to involve multiple mechanisms including persistent inflammation, coagulopathy, autoimmunity, and organ damage. Studies suggest that microclots, also known as fibrinaloids, play a role in Long COVID. In this context, we developed a method to quantify microclots and investigated the relationship between microclot counts and Long COVID. We show that as a cohort, platelet-poor plasma from Long COVID samples had a higher microclot count compared to control groups but retained a wide distribution of counts. Recent COVID-19 infections were also seen to be associated with microclot counts higher than the control groups and equivalent to the Long COVID cohort, with a subsequent time-dependent reduction of counts. Our findings suggest that microclots could be a potential biomarker of disease and/or a treatment target in some Long COVID patients.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy 94%
- Results of an early second PCR test performed on SARS-CoV-2 positive patients may indicate risk for severe COVID-19 92%
- Validating quantitative PCR assays for cell-free DNA detection without DNA extraction: Exercise induced kinetics in systemic lupus erythematosus patients 92%
Similar papers in this journal
- Diagnostic Efficacy of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study 94%
- An “In-House” ELISA for SARS-CoV-2 RBD uncovers elevated immune response at higher altitudes 93%
- Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms 92%
Similar papers in this journal
- The COVID HOME study research protocol: Prospective cohort study of non-hospitalised COVID-19 patients 93%
- Novel prognostic determinants of COVID-19-related mortality: a pilot study on severely-ill patients in Russia 93%
- Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals 93%
Similar papers in this journal
- Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection 94%
- Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact 93%
- Changes to the sebum lipidome upon COVID-19 infection observed via non-invasive and rapid sampling from the skin 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.